Deutsche Bank
ASMB icon

Deutsche Bank’s Assembly Biosciences ASMB Stock Holding History

Deutsche Bank’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,724
Closed -$96K – 4591
2021
Q1 		$96K Sell
1,724
-156
-8% -$10.3K ﹤0.01% 3996
2020
Q4 		$137K Buy
1,880
+55
+3% +$6.45K ﹤0.01% 3668
2020
Q3 		$361K Buy
1,825
+281
+18% +$70.8K ﹤0.01% 2834
2020
Q2 		$432K Sell
1,544
-2,721
-64% -$635K ﹤0.01% 2729
2020
Q1 		$758K Sell
4,265
-1,396
-25% -$299K ﹤0.01% 2247
2019
Q4 		$1.39M Sell
5,661
-6,376
-53% -$1.17M ﹤0.01% 2185
2019
Q3 		$1.42M Sell
12,037
-5,363
-31% -$811K ﹤0.01% 2117
2019
Q2 		$2.81M Buy
17,400
+11,604
+200% +$2.21M ﹤0.01% 2170
2019
Q1 		$1.37M Buy
5,796
+1,245
+27% +$315K ﹤0.01% 2773
2018
Q4 		$1.23M Sell
4,551
-984
-18% -$285K ﹤0.01% 2734
2018
Q3 		$2.47M Sell
5,535
-38
-0.7% -$17.8K ﹤0.01% 2718
2018
Q2 		$2.62M Buy
5,573
+3,338
+149% +$1.77M ﹤0.01% 2781
2018
Q1 		$1.32M Sell
2,235
-724
-24% -$449K ﹤0.01% 3146
2017
Q4 		$1.6M Sell
2,959
-1,830
-38% -$828K ﹤0.01% 2884
2017
Q3 		$2M Buy
4,789
+542
+13% +$166K ﹤0.01% 2541
2017
Q2 		$1.05M Buy
4,247
+3,414
+410% +$961K ﹤0.01% 3001
2017
Q1 		$254K Buy
833
+50
+6% +$12.3K ﹤0.01% 3462
2016
Q4 		$114K Buy
+783
New +$116K ﹤0.01% 4007
2016
Q3 		– Sell
-1,381
Closed -$91K – 4898
2016
Q2 		$91K Buy
1,381
+148
+12% +$9.71K ﹤0.01% 4156
2016
Q1 		$73K Buy
1,233
+836
+211% +$55.9K ﹤0.01% 4173
2015
Q4 		$35K Buy
397
+67
+20% +$7.3K ﹤0.01% 4563
2015
Q3 		$37K Buy
330
+43
+15% +$7.56K ﹤0.01% 4559
2015
Q2 		$66K Buy
+287
New +$55.4K ﹤0.01% 4453
2014
Q2 		– Sell
-1,441
Closed -$109K – 5869
2014
Q1 		$109K Sell
1,441
-1,444
-50% -$225K ﹤0.01% 4191
2013
Q4 		$659K Sell
2,885
-5,145
-64% -$937K ﹤0.01% 2910
2013
Q3 		$1.39M Sell
8,030
-1,605
-17% -$246K ﹤0.01% 2711
2013
Q2 		$1.39M Buy
+9,635
New +$1.51M ﹤0.01% 2467

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Deutsche Bank's ASMB Position: Q2 2021 in Review

Deutsche Bank sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 1,724 shares — an estimated $96K sold.

Deutsche Bank first reported a position in ASMB in Q2 2013 and held it in 27 quarters. The position peaked at $2.81M in Q2 2019. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Deutsche Bank reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 1,724 Assembly Biosciences shares in Q2 2021, an estimated $96K.
  • Deutsche Bank first reported a position in Assembly Biosciences in Q2 2013 and held it in 27 quarters.
  • Deutsche Bank's Assembly Biosciences position peaked at $2.81M in Q2 2019.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.